Enveric Biosciences (SLZ0) Financial Statements
Enveric Biosciences Financial Overview
Enveric Biosciences's market cap is currently $5.72M. The company's EPS TTM is $-16.46; its P/E ratio is -0.09; Enveric Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -200.86K | $ -337.49K | $ -408.03K | $ -435.20K | $ -681.61K |
| Operating Income | $ -8.77M | $ -9.63M | $ -16.45M | $ -19.96M | $ -25.94M |
| EBITDA | $ -8.57M | $ -9.23M | $ -16.85M | $ -19.52M | $ -55.74M |
| Net Income | $ -12.13M | $ -9.57M | ― | $ -18.50M | $ -48.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.68M | $ 2.24M | $ 2.29M | $ 17.72M | $ 17.36M |
| Total Assets | $ 5.10M | $ 3.08M | $ 4.30M | $ 19.55M | $ 26.72M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 63.82K | $ 176.30K |
| Net Debt | $ -4.68M | $ -2.24M | $ -2.29M | $ -17.66M | $ -17.18M |
| Total Liabilities | $ 918.40K | $ 1.49M | $ 2.34M | $ 4.00M | $ 4.41M |
| Stockholders' Equity | $ 4.18M | $ 1.59M | $ 1.96M | $ 14.67M | $ 22.31M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.14M | $ -7.73M | $ -14.10M | $ -17.73M | $ -12.32M |
| Operating Cash Flow | $ -8.14M | $ -7.73M | $ -14.09M | $ -17.15M | $ -11.46M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 11.67K | $ -584.16K | $ 2.19M |
| Financing Cash Flow | $ 10.58M | $ 7.67M | $ -1.34M | $ 18.18M | $ 24.90M |
Currency in USD
